These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38931871)

  • 1. Impact of Time on Parameters for Assessing the Microstructure Equivalence of Topical Products: Diclofenac 1% Emulsion as a Case Study.
    Mañez-Asensi A; Hernández MJ; Mangas-Sanjuán V; Salvador A; Merino-Sanjuán M; Merino V
    Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical bioequivalence: Experimental and regulatory considerations following formulation complexity.
    Miranda M; Veloso C; Brown M; C Pais AAC; Cardoso C; Vitorino C
    Int J Pharm; 2022 May; 620():121705. PubMed ID: 35358644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot Equivalence Study Comparing Different Batches of Topical 0.025% Capsaicin Emulsion: Product Microstructure, Release, and Permeation Evaluation.
    Navarro-Pujol F; Bulut S; Hessman C; Karabelas K; Nieto C; Fernandez-Campos F
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between rheological properties, in vitro release and in vivo equivalency of topical formulations of diclofenac.
    Pleguezuelos-Villa M; Merino-Sanjuán M; Hernández MJ; Nácher A; Peris D; Hidalgo I; Soler L; Sallan M; Merino V
    Int J Pharm; 2019 Dec; 572():118755. PubMed ID: 31715355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drilling down the bioequivalence assessment of topical antifungal products: Microstructure and release.
    Miranda M; Cardoso C; Pais AACC; Brown M; Vitorino C
    Eur J Pharm Biopharm; 2023 Apr; 185():94-106. PubMed ID: 36806630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical drug delivery by Sepineo P600 emulgel: Relationship between rheology, physical stability, and formulation performance.
    Badruddoza AZM; Zahid MI; Walsh T; Shah J; Gates D; Yeoh T; Nurunnabi M
    Int J Pharm; 2024 Jun; 658():124210. PubMed ID: 38718972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoemulsion-based gel formulation of diclofenac diethylamine: design, optimization, rheological behavior and in vitro diffusion studies.
    Hamed R; Basil M; AlBaraghthi T; Sunoqrot S; Tarawneh O
    Pharm Dev Technol; 2016 Dec; 21(8):980-989. PubMed ID: 26369621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API-polymer interactions in Sepineo P600 based topical gel formulation- impact on rheology.
    Badruddoza AZM; Yeoh T; Shah JC
    Int J Pharm; 2022 Jun; 621():121824. PubMed ID: 35569626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diving into Batch-to-Batch Variability of Topical Products-a Regulatory Bottleneck.
    Miranda M; Cova T; Augusto C; Pais AACC; Cardoso C; Vitorino C
    Pharm Res; 2020 Oct; 37(11):218. PubMed ID: 33037479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs.
    Eichner A; Mrestani Y; Hukauf M; Wohlrab J
    Dermatol Ther (Heidelb); 2024 Aug; 14(8):2153-2169. PubMed ID: 38997617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence.
    Mangas-Sanjuán V; Pleguezuelos-Villa M; Merino-Sanjuán M; Hernández MJ; Nácher A; García-Arieta A; Peris D; Hidalgo I; Soler L; Sallan M; Merino V
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31581492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the formulation in the skin delivery of topical diclofenac: not all topical diclofenac formulations are the same.
    Pradal J; Vallet CM; Frappin G; Bariguian F; Lombardi MS
    J Pain Res; 2019; 12():1149-1154. PubMed ID: 31114298
    [No Abstract]   [Full Text] [Related]  

  • 13. The Implications of Regulatory Framework for Topical Semisolid Drug Products: From Critical Quality and Performance Attributes towards Establishing Bioequivalence.
    Ilić T; Pantelić I; Savić S
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34068036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and Evaluation of the In Vitro Performance of Topical Dermatological Products Containing Diclofenac Sodium.
    Manian M; Jain P; Vora D; Banga AK
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viscoelastic and Deformation Characteristics of Structurally Different Commercial Topical Systems.
    Dabbaghi M; Namjoshi S; Panchal B; Grice JE; Prakash S; Roberts MS; Mohammed Y
    Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies into establishing therapeutic bioequivalence of complex topical products: Weight of evidence.
    Miranda M; Volmer Z; Cornick A; Goody A; Cardoso C; Pais AACC; Brown M; Vitorino C
    Int J Pharm; 2024 May; 656():124012. PubMed ID: 38537923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union.
    García-Arieta A; Gordon J; Gwaza L; Merino V; Mangas-Sanjuan V
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of new partial AUC parameters for evaluating the bioequivalence of prolonged-release formulations.
    Boily M; Dussault C; Massicotte J; Guibord P; Lefebvre M
    Eur J Pharm Sci; 2015 Jan; 66():70-7. PubMed ID: 25312344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viscoelastic evaluation of topical creams containing microcrystalline cellulose/sodium carboxymethyl cellulose as stabilizer.
    Adeyeye MC; Jain AC; Ghorab MK; Reilly WJ
    AAPS PharmSciTech; 2002; 3(2):E8. PubMed ID: 12916945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Biodistribution: A High-Resolution Methodology to Assess Bioequivalence in Topical Skin Delivery.
    Quartier J; Capony N; Lapteva M; Kalia YN
    Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31540410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.